Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
SOX2+ Cell Population from Normal Human Brain White Matter Is Able to Generate Mature Oligodendrocytes.
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Increased Signal Intensity in the Dentate Nucleus of Patients with Multiple Sclerosis in Comparison with Neuromyelitis Optica Spectrum Disorder after Multiple Doses of Gadolinium Contrast.
Change in autoantibody and cytokine responses during the evolution of neuromyelitis optica in patients with systemic lupus erythematosus: A preliminary study.
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.
Cognitive Effects of Modafinil in Patients With Multiple Sclerosis: A Clinical Trial.
Perspectives on neuroreparative therapies for treating multiple sclerosis.
[Effective rehabilitation of hospitalized patients with multiple sclerosis].
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.
Altered terminal Schwann cell morphology precedes denervation in SOD1 mice.
Effectiveness of multi-disciplinary rehabilitation for patients with Neuromyelitis Optica.
Dysregulation of ErbB Receptor Trafficking and Signaling in Demyelinating Charcot-Marie-Tooth Disease.
Implications for multiple sclerosis in the era of the Affordable Care Act: the shifting managed care landscape.
Relapsing-remitting multiple sclerosis: patterns of response to disease-modifying therapies and associated factors: a national survey.
[Diagnostic criteria for neuromyelitisoptica spectrum disorders].
Schwann cells-axon interaction in myelination.
Comprehensive Review of Ocular Angiostrongyliasis with Special Reference to Optic Neuritis.
Pertussis toxin attenuates experimental autoimmune encephalomyelitis by upregulating neuronal vascular endothelial growth factor.
Effects of Coenzyme Q10 on the ratio of TH1/TH2 in Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis in C57BL/6.
Elderly-onset neuromyelitis optica spectrum disorders.
Ubiquitin-independent proteosomal degradation of myelin basic protein contributes to development of neurodegenerative autoimmunity.
Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood brain barrier.
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis.
Evaluating the Role of Corticosteroid Pulse Therapy in Patients With Secondary Progressive Multiple Sclerosis Receiving Mitoxantrone: A Double Blind Randomized Controlled Clinical Trial.
Pages
« first
‹ previous
…
669
670
671
672
673
674
675
676
677
…
next ›
last »